Biodesix, Inc.
Biodesix, Inc. (BDSX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
bdsx · stock forecast · 7 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 7 Wall Street analysts in the past 3 months
Buy
7 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$20.00
Consensus
$8.67
-42.0% upside
Low
$3.00
Median: $3 · Last Close: $14.95
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$8.67
-42.0% upside
High Target
$20
33.8%
Low Target
$3
-79.9%
Current Price
$14.95
as of today
Based on analyst price targets, the BDSX stock price prediction for the next 12 months ranges from $3 to $20. The consensus BDSX price forecast of $8.67 implies -42.0% upside from the current price of $14.95.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $15.29 | ↑ 2.26% |
1-day model range: $15.08–$15.49. Peak: $15.49 (+2.26%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · BDSX · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-05 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-02-27 | William Blair | Upgrade ↑ | Market Perform→Outperform |
| 2026-02-17 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-09-19 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-05-21 | Scotiabank | Maintains | Sector Outperform→Sector Outperform |
| 2025-05-14 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-05-14 | Lake Street | Maintains | Buy→Buy |
| 2025-05-14 | Craig-Hallum | Maintains | Buy→Buy |
| 2025-05-14 | William Blair | Downgrade ↓ | Outperform→Market Perform |
| 2025-04-29 | Canaccord Genuity | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Biodesix, Inc. (BDSX) stock. Of the recent 20 rating actions, 1 were upgrades and 2 were downgrades. 7 analysts currently cover BDSX.
Analyst Recommendation Trends
BDSX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$111M
↓ 28.7% YoY
Revenue Next Year
$133M
↑ 19.6% YoY
EPS This Year
$-3.02
EPS Next Year
$-1.82
↓ 39.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast BDSX EPS of $-3.02 for the current fiscal year, based on estimates from 3 analysts. The BDSX revenue forecast is $111M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The BDSX stock forecast is supported by two independent data sources: analyst consensus ratings from 7 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BDSX price target is $8.67 (-42.0% upside), with an analyst consensus of Buy.
The BDSX short-term stock prediction for tomorrow is $15.29 (+2.26%).
Biodesix, Inc. trades on NASDAQ under the ticker BDSX. The BDSX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 86% of covering analysts.
Frequently asked questions
BDSX forecast · 8 questionsAccording to 7 Wall Street analysts, the average 12-month BDSX price target is $8.67, with a high forecast of $20.00 and a low of $3.00. The median price target is shown in the chart above when available. This implies -42.0% potential upside from the current price of $14.95.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.